Most cancer care still treats populations — not people.
In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, introduces OncoMeta, a revolutionary precision ecosystem that designs custom cancer treatment programs based entirely on each patient’s unique biology. Instead of guessing, OncoMeta maps your DNA, RNA, and immune spatial biology to reveal every cancer driver and immune blockade — then builds personalized medications, delivery systems, and immune retraining therapies around it.
This next-generation model moves beyond standard “one-size-fits-all” guidelines to a fully integrated system combining molecular mapping, targeted microdosing, and immune activation. The result: smarter drug delivery, fewer side effects, and higher response rates.
🎯 What You’ll Learn in This Episode:
• Why standard cancer treatments fail to account for immune terrain and tumor microenvironments
• How OncoMeta integrates DNA, RNA, and immune spatial biology for deep targeting
• The role of precision mapping in designing microdosed, immune-centered therapies
• Why less chemo, given precisely, often delivers better results
• How interventional oncology delivers medication directly to the tumor site
• Why immune-centric care leads to long-term remission and better quality of life
📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak to a care coordinator: 866-830-4576
“You don’t need more treatment — you need the right treatment. Precision changes everything.”
Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.
You can read the full peer-reviewed study at:
https://www.scirp.org/journal/paperinformation?paperid=132493
